Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Pisano

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2013
Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapyEmanuela Grassilli, Robert Narloch, Elena Federzoni, et al.
Vaccine|October 12, 2023
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in GermanyInci Aydin, Marcus May, Fabio Pisano, et al.
The Review of Scientific Instruments|November 8, 2018
Infrared imaging systems for wall protection in the W7-X stellarator (invited)Marcin Jakubowski, Peter Drewelow, Joris Fellinger, et al.
The Journal of Pathology|September 14, 2019
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancersMarialuisa Lavitrano, Leonarda Ianzano, Sara Bonomo, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2013
Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapyEmanuela Grassilli, Robert Narloch, Elena Federzoni, et al.
Vaccine|October 12, 2023
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in GermanyInci Aydin, Marcus May, Fabio Pisano, et al.
The Review of Scientific Instruments|November 8, 2018
Infrared imaging systems for wall protection in the W7-X stellarator (invited)Marcin Jakubowski, Peter Drewelow, Joris Fellinger, et al.
The Journal of Pathology|September 14, 2019
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancersMarialuisa Lavitrano, Leonarda Ianzano, Sara Bonomo, et al.
Pageof 3